Feed / PRTA

Prothena Corporation plc

PRTA

Healthcare · 9.43 +0.5% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Prothena Corporation plc's current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 19 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.

Company+0.5% todayVolume comparison unavailable
Market group0 of 19 activeConsumer Health & Finance · unavailable
Disclosed network0 of 6 confirmingNo filing-linked name is confirming now
What would change this read
  • PRTA's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if PRTA's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind PRTA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BMYBristol-Myers Squibb CompanypartnerMay 7, 2026

Our active clinical portfolio includes prasinezumab currently being evaluated in the Phase 3 PARAISO clinical trial for the treatment of early Parkinson’s disease in partnership with Roche, coramitug currently being evaluated in the Phase 3 CLEOPATTRA clinica…

NVONovo Nordisk A/SinvesteeFeb 27, 2026

ATTR Amyloidosis Business Acquired by Novo Nordisk In July 2021, we announced that we and Novo Nordisk entered into a definitive purchase agreement under which Novo Nordisk acquired our clinical stage antibody coramitug and broader ATTR amyloidosis business.

Depended on by

DNLIDenali Therapeutics Inc. Common StockcompetitorFeb 26, 2026

Additionally, potentially disease modifying therapeutics are being developed by several large and specialty pharmaceutical and biotechnology companies, including Biogen/lonis, Arrowhead, Eli Lilly (including Prevail Therapeutics, its wholly owned subsidiary),…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

PRTA is currently a Early Follower in the organic co-movement group Consumer Health & Finance. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for PRTA; it is not active in the latest market snapshot.